| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K78574327 |
| PharmacoGx | BRD-K78574327 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLXNA3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | CLIP4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | USMG5 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | MARCKS | CTRPv2 | pan-cancer | AAC | 0.17 | 0.06 |
| mRNA | VAT1L | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | SCAMP5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | CD81 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | ADRA1B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | CCDC126 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | CLK2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
